Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

GSK - The breakthrough era in endometrial cancer treatment

Synergy: Is it more than a buzzword for IO plus PARPi or TKI?

Date

22 Oct 2023

Session

GSK - The breakthrough era in endometrial cancer treatment

Topics

Tumour Site

Endometrial Cancer

Presenters

Kathleen Moore

Authors

K.N. Moore

Author affiliations

Department Of Obstetrics And Gynecology University, Stephenson Cancer Center/University of Oklahoma, 73104 - Oklahoma City/US

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

22 Oct 2023

Three ways EC management is changing

Presenter: Christian Marth

Session: GSK - The breakthrough era in endometrial cancer treatment

Resources:

Webcast

22 Oct 2023

Anti–PD-(L)1s plus chemotherapies continue to evolve: Updates from 2023 congresses

Presenter: Ilaria Colombo

Session: GSK - The breakthrough era in endometrial cancer treatment

Resources:

Webcast

22 Oct 2023

Surge in molecular-based targets brings new hope for EC treatment

Presenter: All Speakers

Session: GSK - The breakthrough era in endometrial cancer treatment

Resources:

Webcast

22 Oct 2023

Full discussion/Q&A

Presenter: All Speakers

Session: GSK - The breakthrough era in endometrial cancer treatment

Resources:

Webcast